Difference between revisions of "Schistosomiasis Control Initiative"

From Ref
Jump to: navigation, search
Line 24: Line 24:
 
! Item !! Value
 
! Item !! Value
 
|-
 
|-
| Countries of operation || 8-10 African countries
+
| Countries of operation || 8-10 African countries (which countries? Difficult to glean)
 
|-
 
|-
 
| Headquarters || Imperial College, London, United Kingdom
 
| Headquarters || Imperial College, London, United Kingdom
Line 32: Line 32:
 
| Method summary || Advocate for the benefits of mass drug distributions to government officials.<br>Assist with planning and fund raising.<br>Deliver funding and drugs to governments.<br>Provide financial management and technical support.<br>Develop procedures for monitoring and evaluation.
 
| Method summary || Advocate for the benefits of mass drug distributions to government officials.<br>Assist with planning and fund raising.<br>Deliver funding and drugs to governments.<br>Provide financial management and technical support.<br>Develop procedures for monitoring and evaluation.
 
|-
 
|-
| Previous sources of funding || grant from [[Gates Foundation]] (private philanthropic foundation)<br>grants from [[USAID]] (US federal grantmaking agency)<br>grants from [[DFID]] (UK central grantmaking agency)
+
| Previous sources of funding || grant from [[Gates Foundation]] (private philanthropic foundation)<br>grants from [[USAID]] (US federal grantmaking agency)<br>grants from [[DFID]] (UK central grantmaking agency). More in the [[#History of operations and funding]] section.
 
|}
 
|}
  
Line 50: Line 50:
  
 
==Operations and history==
 
==Operations and history==
 
Note to GiveWell staff: ignore the red links, they are meant to be stand-ins for your current internal links to pages.
 
  
 
{{quotation|To understand this section better, follow the links to get more background information on these topics:<br>[[neglected tropical diseases]] (NTDs): diseases that currently afflict people largely in low-income tropical areas, particularly Africa, and are ''neglected'' by most research efforts in the developed world because they do not cause much trouble in developed world countries.<br>List of NTDs mentioned here: [[schistosomiasis]], [[soil-transmitted helminth]]s (acronym '''STH'''s), [[lymphatic filariasis]], [[onchocerciasis]], and [[trachoma]].<br>[[mass drug administration program]]: {{fillin}} }}  
 
{{quotation|To understand this section better, follow the links to get more background information on these topics:<br>[[neglected tropical diseases]] (NTDs): diseases that currently afflict people largely in low-income tropical areas, particularly Africa, and are ''neglected'' by most research efforts in the developed world because they do not cause much trouble in developed world countries.<br>List of NTDs mentioned here: [[schistosomiasis]], [[soil-transmitted helminth]]s (acronym '''STH'''s), [[lymphatic filariasis]], [[onchocerciasis]], and [[trachoma]].<br>[[mass drug administration program]]: {{fillin}} }}  
Line 79: Line 77:
 
|-
 
|-
 
| [[DFID]] (UK central grantmaking agency) || 2010 || ? || schistosomiasis, STHs || eight African countries (same eight?) || Till 2015 (?), five year grant || Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>
 
| [[DFID]] (UK central grantmaking agency) || 2010 || ? || schistosomiasis, STHs || eight African countries (same eight?) || Till 2015 (?), five year grant || Other NTDs are not covered by the grant, <toggledisplay>though DFID also provided funding to the Liverpool School of Tropical Medicine to integrate treatment for lymphatic filariasis with SCI-funded schistosomiasis and STH programs in six countries</toggledisplay>
 +
|-
 +
! Total !! -- !! add up !! -- !! --
 
|}
 
|}
  
Line 85: Line 85:
 
{{fillin}} -- long and tedious
 
{{fillin}} -- long and tedious
  
===Overall spending beakdown===
+
===Overall spending breakdown===
  
 
{{fillin}} -- long and tedious
 
{{fillin}} -- long and tedious

Revision as of 07:30, 19 February 2013

Summary

Evaluation on key parameters

Schistosomiasis Control Initiative (SCI) is a recommended organization.

Parameter One-word summary More details (section in this page)
Evidence of effectiveness Strong #Independent evidence of program effectiveness
Cost-effectiveness Excellent #Independent evidence of program effectiveness
Funding gap aka room for more funding Significant #Room for more funding
Transparency  ?  ?
Monitoring and evaluation Strong #Internal monitoring: large-scale programs

Summary of who they are and what they do

Item Value
Countries of operation 8-10 African countries (which countries? Difficult to glean)
Headquarters Imperial College, London, United Kingdom
Goals Create or scale up mass drug administration programs for neglected tropical diseases (NTD), particularly schistosomiasis and soil-transmitted helminths (STHs), in school-aged children and other groups determined to be at high risk.
Method summary Advocate for the benefits of mass drug distributions to government officials.
Assist with planning and fund raising.
Deliver funding and drugs to governments.
Provide financial management and technical support.
Develop procedures for monitoring and evaluation.
Previous sources of funding grant from Gates Foundation (private philanthropic foundation)
grants from USAID (US federal grantmaking agency)
grants from DFID (UK central grantmaking agency). More in the #History of operations and funding section.

Review process

The review of SCI began in 2009. Below are details of the kind of inputs used in the review process.

What we sought to learn How we learned it
Effectiveness and other effects of these kinds of programs Study of the published literature
Details and big picture of SCI's operations Extensive communications with SCI Director Alan Fenwick to discuss SCI's methods and funding needs
meetings with other staff at SCI's headquarters in London
Requesting and reviewing SCI internal financial and organizational documents.
Feel for how SCI's programs are run on the ground Visiting a national schistosomiasis control program meeting and demonstration mass drug administration in Malawi (site visit: October 2011)

Operations and history

To understand this section better, follow the links to get more background information on these topics:
neglected tropical diseases (NTDs): diseases that currently afflict people largely in low-income tropical areas, particularly Africa, and are neglected by most research efforts in the developed world because they do not cause much trouble in developed world countries.
List of NTDs mentioned here: schistosomiasis, soil-transmitted helminths (acronym STHs), lymphatic filariasis, onchocerciasis, and trachoma.
mass drug administration program: Fill this in later

Broad description of goals and methods

SCI's goal is to create or scale up mass drug administration programs for neglected tropical diseases (NTD), particularly schistosomiasis and soil-transmitted helminths (STHs), in school-aged children and other groups determined to be at high risk. They list the following five methods:

  • Advocate for the benefits of mass drug distributions to government officials in the African countries
  • Assist with planning and fund raising
  • Deliver funding and drugs to governments
  • Provide financial management and technical support
  • Develop procedures for monitoring and evaluation

History of operations and funding

Below are some of the important funders and details of the programs funded (the ?s reflect things that weren't clear from GiveWell's page but can be dug up from the original sources, I'm sure):

Funder Year of funding Amount of funding Neglected Tropical Diseases (NTDs) tackled Countries tackled Expiry of grant Additional comments
Gates Foundation (private philanthropic foundation that makes grants for developing world health charities) 2002 $32 million schistosomiasis, STHs six African countries: Fill this in later unspecified This was a founding grant.
USAID (US federal grantmaking agency) and Gates Foundation 2006  ? schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma eight African countries: Fill this in later Till 2011 (five year grant)
 ? 2007  ? schistosomiasis, STHs, lymphatic filariasis, onchocerciasis, and trachoma Rwanda and Burundi Till 2011 This was intended to expand the program from the eight current countries of operation to these two new countries.
DFID (UK central grantmaking agency) 2010  ? schistosomiasis, STHs eight African countries (same eight?) Till 2015 (?), five year grant Other NTDs are not covered by the grant, [SHOW MORE]
Total -- add up -- --

Other projects

Fill this in later -- long and tedious

Overall spending breakdown

Fill this in later -- long and tedious

Does it work?

Independent evidence of program effectiveness

Fill this in later